nodes	percent_of_prediction	percent_of_DWPC	metapath
Methadone—HTR3A—enteric nervous system—narcolepsy	0.287	0.451	CbGeAlD
Methadone—GRIN3A—forebrain—narcolepsy	0.0447	0.0703	CbGeAlD
Methadone—OPRD1—forebrain—narcolepsy	0.0315	0.0496	CbGeAlD
Methadone—OPRK1—forebrain—narcolepsy	0.0302	0.0475	CbGeAlD
Methadone—HTR3A—brainstem—narcolepsy	0.0243	0.0382	CbGeAlD
Methadone—HTR3A—forebrain—narcolepsy	0.0235	0.0369	CbGeAlD
Methadone—OPRM1—brainstem—narcolepsy	0.0223	0.035	CbGeAlD
Methadone—OPRM1—forebrain—narcolepsy	0.0215	0.0338	CbGeAlD
Methadone—GRIN3A—brain—narcolepsy	0.0186	0.0292	CbGeAlD
Methadone—CYP19A1—forebrain—narcolepsy	0.0181	0.0284	CbGeAlD
Methadone—OPRM1—midbrain—narcolepsy	0.0142	0.0223	CbGeAlD
Methadone—OPRD1—brain—narcolepsy	0.0131	0.0206	CbGeAlD
Methadone—OPRK1—brain—narcolepsy	0.0125	0.0197	CbGeAlD
Methadone—HTR3A—brain—narcolepsy	0.00973	0.0153	CbGeAlD
Methadone—CYP2D6—brainstem—narcolepsy	0.00893	0.014	CbGeAlD
Methadone—OPRM1—brain—narcolepsy	0.00892	0.014	CbGeAlD
Methadone—CYP2D6—forebrain—narcolepsy	0.00862	0.0136	CbGeAlD
Methadone—CYP19A1—brain—narcolepsy	0.00749	0.0118	CbGeAlD
Methadone—ABCB1—forebrain—narcolepsy	0.0062	0.00975	CbGeAlD
Methadone—OPRD1—Peptide ligand-binding receptors—HCRTR1—narcolepsy	0.00559	0.0157	CbGpPWpGaD
Methadone—OPRD1—Peptide ligand-binding receptors—HCRTR2—narcolepsy	0.00559	0.0157	CbGpPWpGaD
Methadone—CYP2C8—brain—narcolepsy	0.00537	0.00844	CbGeAlD
Methadone—OPRK1—Peptide ligand-binding receptors—HCRTR2—narcolepsy	0.0049	0.0137	CbGpPWpGaD
Methadone—OPRK1—Peptide ligand-binding receptors—HCRTR1—narcolepsy	0.0049	0.0137	CbGpPWpGaD
Methadone—CYP2B6—brain—narcolepsy	0.00481	0.00757	CbGeAlD
Methadone—OPRD1—Peptide ligand-binding receptors—HCRT—narcolepsy	0.00459	0.0129	CbGpPWpGaD
Methadone—ABCB1—medulla oblongata—narcolepsy	0.00448	0.00704	CbGeAlD
Methadone—OPRD1—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00437	0.0123	CbGpPWpGaD
Methadone—OPRD1—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00437	0.0123	CbGpPWpGaD
Methadone—HTR3A—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.00435	0.0122	CbGpPWpGaD
Methadone—OPRD1—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00422	0.0118	CbGpPWpGaD
Methadone—OPRM1—Peptide ligand-binding receptors—HCRTR1—narcolepsy	0.00414	0.0116	CbGpPWpGaD
Methadone—OPRM1—Peptide ligand-binding receptors—HCRTR2—narcolepsy	0.00414	0.0116	CbGpPWpGaD
Methadone—ABCB1—midbrain—narcolepsy	0.00409	0.00644	CbGeAlD
Methadone—OPRD1—Peptide ligand-binding receptors—PENK—narcolepsy	0.00409	0.0115	CbGpPWpGaD
Methadone—OPRK1—Peptide ligand-binding receptors—HCRT—narcolepsy	0.00402	0.0113	CbGpPWpGaD
Methadone—OPRK1—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00383	0.0108	CbGpPWpGaD
Methadone—OPRK1—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00383	0.0108	CbGpPWpGaD
Methadone—OPRD1—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00375	0.0105	CbGpPWpGaD
Methadone—OPRD1—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00375	0.0105	CbGpPWpGaD
Methadone—OPRK1—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.0037	0.0104	CbGpPWpGaD
Methadone—OPRD1—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00362	0.0102	CbGpPWpGaD
Methadone—OPRK1—Peptide ligand-binding receptors—PENK—narcolepsy	0.00359	0.0101	CbGpPWpGaD
Methadone—CYP2D6—brain—narcolepsy	0.00358	0.00562	CbGeAlD
Methadone—OPRD1—Peptide ligand-binding receptors—TRH—narcolepsy	0.00348	0.00975	CbGpPWpGaD
Methadone—OPRD1—G alpha (i) signalling events—PENK—narcolepsy	0.00345	0.00968	CbGpPWpGaD
Methadone—OPRM1—Peptide ligand-binding receptors—HCRT—narcolepsy	0.0034	0.00954	CbGpPWpGaD
Methadone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00329	0.00922	CbGpPWpGaD
Methadone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00329	0.00922	CbGpPWpGaD
Methadone—OPRM1—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00324	0.00909	CbGpPWpGaD
Methadone—OPRM1—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00324	0.00909	CbGpPWpGaD
Methadone—OPRK1—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00317	0.0089	CbGpPWpGaD
Methadone—OPRM1—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00313	0.00878	CbGpPWpGaD
Methadone—OPRD1—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00308	0.00863	CbGpPWpGaD
Methadone—OPRK1—Peptide ligand-binding receptors—TRH—narcolepsy	0.00305	0.00855	CbGpPWpGaD
Methadone—OPRM1—Peptide ligand-binding receptors—PENK—narcolepsy	0.00303	0.0085	CbGpPWpGaD
Methadone—OPRK1—G alpha (i) signalling events—PENK—narcolepsy	0.00302	0.00848	CbGpPWpGaD
Methadone—OPRD1—GPCR ligand binding—HCRTR2—narcolepsy	0.00285	0.008	CbGpPWpGaD
Methadone—OPRD1—GPCR ligand binding—HCRTR1—narcolepsy	0.00285	0.008	CbGpPWpGaD
Methadone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00278	0.00779	CbGpPWpGaD
Methadone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00278	0.00779	CbGpPWpGaD
Methadone—OPRD1—GPCR ligand binding—P2RY11—narcolepsy	0.00276	0.00773	CbGpPWpGaD
Methadone—OPRD1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00274	0.00769	CbGpPWpGaD
Methadone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.0027	0.00757	CbGpPWpGaD
Methadone—OPRM1—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00268	0.00752	CbGpPWpGaD
Methadone—HTR3A—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.00262	0.00734	CbGpPWpGaD
Methadone—OPRM1—Peptide ligand-binding receptors—TRH—narcolepsy	0.00258	0.00723	CbGpPWpGaD
Methadone—ABCB1—brain—narcolepsy	0.00257	0.00404	CbGeAlD
Methadone—OPRD1—G alpha (i) signalling events—HRH3—narcolepsy	0.00257	0.00721	CbGpPWpGaD
Methadone—OPRM1—G alpha (i) signalling events—PENK—narcolepsy	0.00256	0.00717	CbGpPWpGaD
Methadone—OPRD1—Peptide ligand-binding receptors—NPS—narcolepsy	0.00253	0.00709	CbGpPWpGaD
Methadone—OPRD1—Peptide ligand-binding receptors—TAC1—narcolepsy	0.00253	0.00709	CbGpPWpGaD
Methadone—OPRK1—GPCR ligand binding—HCRTR2—narcolepsy	0.0025	0.00702	CbGpPWpGaD
Methadone—OPRK1—GPCR ligand binding—HCRTR1—narcolepsy	0.0025	0.00702	CbGpPWpGaD
Methadone—OPRK1—GPCR ligand binding—P2RY11—narcolepsy	0.00242	0.00678	CbGpPWpGaD
Methadone—OPRK1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.0024	0.00675	CbGpPWpGaD
Methadone—OPRD1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00239	0.0067	CbGpPWpGaD
Methadone—OPRD1—GPCR ligand binding—HCRT—narcolepsy	0.00234	0.00657	CbGpPWpGaD
Methadone—OPRD1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00233	0.00654	CbGpPWpGaD
Methadone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00228	0.0064	CbGpPWpGaD
Methadone—OPRK1—G alpha (i) signalling events—HRH3—narcolepsy	0.00226	0.00633	CbGpPWpGaD
Methadone—OPRK1—Peptide ligand-binding receptors—TAC1—narcolepsy	0.00221	0.00621	CbGpPWpGaD
Methadone—OPRK1—Peptide ligand-binding receptors—NPS—narcolepsy	0.00221	0.00621	CbGpPWpGaD
Methadone—OPRM1—GPCR ligand binding—HCRTR2—narcolepsy	0.00211	0.00593	CbGpPWpGaD
Methadone—OPRM1—GPCR ligand binding—HCRTR1—narcolepsy	0.00211	0.00593	CbGpPWpGaD
Methadone—Atomoxetine—HTR2A—narcolepsy	0.00211	0.281	CrCbGaD
Methadone—OPRK1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00209	0.00587	CbGpPWpGaD
Methadone—OPRD1—GPCR ligand binding—PENK—narcolepsy	0.00209	0.00586	CbGpPWpGaD
Methadone—OPRK1—GPCR ligand binding—HCRT—narcolepsy	0.00205	0.00576	CbGpPWpGaD
Methadone—OPRK1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00204	0.00574	CbGpPWpGaD
Methadone—OPRD1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00204	0.00574	CbGpPWpGaD
Methadone—OPRM1—GPCR ligand binding—P2RY11—narcolepsy	0.00204	0.00573	CbGpPWpGaD
Methadone—OPRM1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00203	0.0057	CbGpPWpGaD
Methadone—Propiomazine—HTR2A—narcolepsy	0.00198	0.265	CrCbGaD
Methadone—CYP19A1—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00194	0.00543	CbGpPWpGaD
Methadone—OPRM1—G alpha (i) signalling events—HRH3—narcolepsy	0.00191	0.00535	CbGpPWpGaD
Methadone—OPRM1—Peptide ligand-binding receptors—NPS—narcolepsy	0.00187	0.00525	CbGpPWpGaD
Methadone—OPRM1—Peptide ligand-binding receptors—TAC1—narcolepsy	0.00187	0.00525	CbGpPWpGaD
Methadone—OPRK1—GPCR ligand binding—PENK—narcolepsy	0.00183	0.00514	CbGpPWpGaD
Methadone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00179	0.00503	CbGpPWpGaD
Methadone—OPRD1—GPCR ligand binding—TRH—narcolepsy	0.00178	0.00498	CbGpPWpGaD
Methadone—OPRM1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00177	0.00496	CbGpPWpGaD
Methadone—OPRM1—GPCR ligand binding—HCRT—narcolepsy	0.00174	0.00487	CbGpPWpGaD
Methadone—Trimipramine—HTR2A—narcolepsy	0.00173	0.231	CrCbGaD
Methadone—OPRM1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00173	0.00485	CbGpPWpGaD
Methadone—OPRD1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00169	0.00475	CbGpPWpGaD
Methadone—OPRD1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00169	0.00475	CbGpPWpGaD
Methadone—Promethazine—HTR2A—narcolepsy	0.00167	0.223	CrCbGaD
Methadone—OPRD1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00161	0.00452	CbGpPWpGaD
Methadone—OPRD1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00161	0.00452	CbGpPWpGaD
Methadone—OPRD1—GPCR downstream signaling—P2RY11—narcolepsy	0.00156	0.00437	CbGpPWpGaD
Methadone—OPRD1—GPCR ligand binding—HRH3—narcolepsy	0.00156	0.00437	CbGpPWpGaD
Methadone—OPRK1—GPCR ligand binding—TRH—narcolepsy	0.00156	0.00437	CbGpPWpGaD
Methadone—OPRM1—GPCR ligand binding—PENK—narcolepsy	0.00155	0.00434	CbGpPWpGaD
Methadone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00152	0.00425	CbGpPWpGaD
Methadone—OPRK1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00149	0.00417	CbGpPWpGaD
Methadone—OPRK1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00149	0.00417	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—HCRTR2—narcolepsy	0.00146	0.00411	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—HCRTR1—narcolepsy	0.00146	0.00411	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—P2RY11—narcolepsy	0.00141	0.00397	CbGpPWpGaD
Methadone—OPRK1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00141	0.00397	CbGpPWpGaD
Methadone—OPRK1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00141	0.00397	CbGpPWpGaD
Methadone—OPRK1—GPCR downstream signaling—P2RY11—narcolepsy	0.00137	0.00383	CbGpPWpGaD
Methadone—OPRK1—GPCR ligand binding—HRH3—narcolepsy	0.00137	0.00383	CbGpPWpGaD
Methadone—ABCB1—Allograft Rejection—HLA-DQA1—narcolepsy	0.00136	0.00383	CbGpPWpGaD
Methadone—OPRD1—GPCR downstream signaling—HCRT—narcolepsy	0.00132	0.00371	CbGpPWpGaD
Methadone—CYP19A1—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00132	0.00369	CbGpPWpGaD
Methadone—OPRM1—GPCR ligand binding—TRH—narcolepsy	0.00132	0.00369	CbGpPWpGaD
Methadone—OPRD1—GPCR ligand binding—TAC1—narcolepsy	0.00129	0.00362	CbGpPWpGaD
Methadone—OPRD1—GPCR ligand binding—NPS—narcolepsy	0.00129	0.00362	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—HCRTR2—narcolepsy	0.00128	0.0036	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—HCRTR1—narcolepsy	0.00128	0.0036	CbGpPWpGaD
Methadone—ABCB1—Allograft Rejection—HLA-DQB1—narcolepsy	0.00128	0.00358	CbGpPWpGaD
Methadone—OPRM1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00126	0.00352	CbGpPWpGaD
Methadone—OPRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00126	0.00352	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—P2RY11—narcolepsy	0.00124	0.00348	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—HCRT—narcolepsy	0.0012	0.00337	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00119	0.00335	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00119	0.00335	CbGpPWpGaD
Methadone—OPRD1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00119	0.00334	CbGpPWpGaD
Methadone—OPRD1—GPCR downstream signaling—PENK—narcolepsy	0.00118	0.00331	CbGpPWpGaD
Methadone—OPRK1—GPCR downstream signaling—HCRT—narcolepsy	0.00116	0.00326	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—P2RY11—narcolepsy	0.00115	0.00324	CbGpPWpGaD
Methadone—OPRM1—GPCR ligand binding—HRH3—narcolepsy	0.00115	0.00324	CbGpPWpGaD
Methadone—OPRK1—GPCR ligand binding—NPS—narcolepsy	0.00113	0.00317	CbGpPWpGaD
Methadone—OPRK1—GPCR ligand binding—TAC1—narcolepsy	0.00113	0.00317	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—CHKB—narcolepsy	0.00113	0.00316	CbGpPWpGaD
Methadone—HTR3A—SIDS Susceptibility Pathways—TNF—narcolepsy	0.00113	0.00316	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—HCRTR2—narcolepsy	0.00109	0.00304	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—HCRTR1—narcolepsy	0.00109	0.00304	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—PENK—narcolepsy	0.00107	0.00301	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—HCRT—narcolepsy	0.00105	0.00296	CbGpPWpGaD
Methadone—CYP2C8—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00105	0.00295	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—P2RY11—narcolepsy	0.00105	0.00294	CbGpPWpGaD
Methadone—OPRK1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00104	0.00293	CbGpPWpGaD
Methadone—OPRK1—GPCR downstream signaling—PENK—narcolepsy	0.00103	0.0029	CbGpPWpGaD
Methadone—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00102	0.00286	CbGpPWpGaD
Methadone—OPRD1—GPCR downstream signaling—TRH—narcolepsy	0.001	0.00282	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—HCRT—narcolepsy	0.000981	0.00275	CbGpPWpGaD
Methadone—ABCB1—Allograft Rejection—HLA-DRB1—narcolepsy	0.00097	0.00272	CbGpPWpGaD
Methadone—OPRM1—GPCR ligand binding—NPS—narcolepsy	0.000956	0.00268	CbGpPWpGaD
Methadone—OPRM1—GPCR ligand binding—TAC1—narcolepsy	0.000956	0.00268	CbGpPWpGaD
Methadone—CYP2C19—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00094	0.00264	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—PENK—narcolepsy	0.00094	0.00264	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—TRH—narcolepsy	0.000911	0.00256	CbGpPWpGaD
Methadone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000894	0.00251	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—HCRT—narcolepsy	0.000891	0.0025	CbGpPWpGaD
Methadone—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000882	0.00247	CbGpPWpGaD
Methadone—OPRK1—GPCR downstream signaling—TRH—narcolepsy	0.00088	0.00247	CbGpPWpGaD
Methadone—OPRD1—GPCR downstream signaling—HRH3—narcolepsy	0.00088	0.00247	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—PENK—narcolepsy	0.000875	0.00245	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—HCRTR2—narcolepsy	0.000865	0.00243	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—HCRTR1—narcolepsy	0.000865	0.00243	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—CHKB—narcolepsy	0.000862	0.00242	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.000857	0.0024	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—P2RY11—narcolepsy	0.000835	0.00234	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—TRH—narcolepsy	0.000799	0.00224	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—HRH3—narcolepsy	0.000799	0.00224	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—PENK—narcolepsy	0.000794	0.00223	CbGpPWpGaD
Methadone—OPRD1—GPCR ligand binding—HTR2A—narcolepsy	0.000776	0.00218	CbGpPWpGaD
Methadone—OPRK1—GPCR downstream signaling—HRH3—narcolepsy	0.000772	0.00216	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—CPT1B—narcolepsy	0.000766	0.00215	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—HCRTR2—narcolepsy	0.000758	0.00213	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—HCRTR1—narcolepsy	0.000758	0.00213	CbGpPWpGaD
Methadone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000755	0.00212	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—CHKB—narcolepsy	0.000749	0.0021	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—TRH—narcolepsy	0.000744	0.00209	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—P2RY11—narcolepsy	0.000733	0.00206	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.000732	0.00205	CbGpPWpGaD
Methadone—OPRD1—GPCR downstream signaling—TAC1—narcolepsy	0.000729	0.00205	CbGpPWpGaD
Methadone—OPRD1—GPCR downstream signaling—NPS—narcolepsy	0.000729	0.00205	CbGpPWpGaD
Methadone—CYP2C8—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000716	0.00201	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—HCRT—narcolepsy	0.00071	0.00199	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—HRH3—narcolepsy	0.000701	0.00197	CbGpPWpGaD
Methadone—OPRK1—GPCR ligand binding—HTR2A—narcolepsy	0.000681	0.00191	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—TRH—narcolepsy	0.000675	0.00189	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—NPS—narcolepsy	0.000662	0.00186	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—TAC1—narcolepsy	0.000662	0.00186	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—HRH3—narcolepsy	0.000652	0.00183	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—HCRTR2—narcolepsy	0.000641	0.0018	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—HCRTR1—narcolepsy	0.000641	0.0018	CbGpPWpGaD
Methadone—OPRK1—GPCR downstream signaling—NPS—narcolepsy	0.000639	0.00179	CbGpPWpGaD
Methadone—OPRK1—GPCR downstream signaling—TAC1—narcolepsy	0.000639	0.00179	CbGpPWpGaD
Methadone—CYP2C19—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000639	0.00179	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—PENK—narcolepsy	0.000633	0.00178	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—HCRT—narcolepsy	0.000623	0.00175	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—P2RY11—narcolepsy	0.000619	0.00174	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—HRH3—narcolepsy	0.000592	0.00166	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—CPT1B—narcolepsy	0.000586	0.00164	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000582	0.00163	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—TAC1—narcolepsy	0.000581	0.00163	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—NPS—narcolepsy	0.000581	0.00163	CbGpPWpGaD
Methadone—OPRM1—GPCR ligand binding—HTR2A—narcolepsy	0.000575	0.00161	CbGpPWpGaD
Methadone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—narcolepsy	0.000564	0.00158	CbGpPWpGaD
Methadone—CYP1A2—Aryl Hydrocarbon Receptor—TNF—narcolepsy	0.000564	0.00158	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—PENK—narcolepsy	0.000555	0.00156	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—CHKB—narcolepsy	0.000554	0.00155	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—CHKB—narcolepsy	0.000541	0.00152	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—TAC1—narcolepsy	0.00054	0.00152	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—NPS—narcolepsy	0.00054	0.00152	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—TRH—narcolepsy	0.000538	0.00151	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—HCRT—narcolepsy	0.000526	0.00148	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—CPT1B—narcolepsy	0.000509	0.00143	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000498	0.0014	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—NPS—narcolepsy	0.000491	0.00138	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—TAC1—narcolepsy	0.000491	0.00138	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—TRH—narcolepsy	0.000472	0.00132	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—HRH3—narcolepsy	0.000472	0.00132	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—PENK—narcolepsy	0.000469	0.00132	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—CHKB—narcolepsy	0.000469	0.00132	CbGpPWpGaD
Methadone—ABCB1—Allograft Rejection—TNF—narcolepsy	0.000458	0.00129	CbGpPWpGaD
Methadone—OPRD1—GPCR downstream signaling—HTR2A—narcolepsy	0.000439	0.00123	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—CHKB—narcolepsy	0.000419	0.00117	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—HRH3—narcolepsy	0.000414	0.00116	CbGpPWpGaD
Methadone—ABCB1—Metabolism—CHKB—narcolepsy	0.000409	0.00115	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—TRH—narcolepsy	0.000399	0.00112	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—HTR2A—narcolepsy	0.000398	0.00112	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—TAC1—narcolepsy	0.000391	0.0011	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—NPS—narcolepsy	0.000391	0.0011	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—CHKB—narcolepsy	0.000385	0.00108	CbGpPWpGaD
Methadone—OPRK1—GPCR downstream signaling—HTR2A—narcolepsy	0.000385	0.00108	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—CHKB—narcolepsy	0.000382	0.00107	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—CPT1B—narcolepsy	0.000376	0.00106	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—CPT1B—narcolepsy	0.000368	0.00103	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—HRH3—narcolepsy	0.00035	0.000981	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—HTR2A—narcolepsy	0.000349	0.00098	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—NPS—narcolepsy	0.000343	0.000962	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—TAC1—narcolepsy	0.000343	0.000962	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—CHKB—narcolepsy	0.000326	0.000915	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—HTR2A—narcolepsy	0.000325	0.000912	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—CPT1B—narcolepsy	0.000319	0.000894	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—HTR2A—narcolepsy	0.000295	0.000828	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—TAC1—narcolepsy	0.00029	0.000813	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—NPS—narcolepsy	0.00029	0.000813	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—CPT1B—narcolepsy	0.000284	0.000798	CbGpPWpGaD
Methadone—ABCB1—Metabolism—CPT1B—narcolepsy	0.000278	0.000779	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—CPT1B—narcolepsy	0.000262	0.000734	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—CPT1B—narcolepsy	0.000259	0.000728	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CHKB—narcolepsy	0.000252	0.000706	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—HTR2A—narcolepsy	0.000235	0.00066	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.000226	0.000635	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—CPT1B—narcolepsy	0.000222	0.000622	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—HTR2A—narcolepsy	0.000206	0.000579	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—HTR2A—narcolepsy	0.000174	0.000489	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CPT1B—narcolepsy	0.000171	0.00048	CbGpPWpGaD
